190 related articles for article (PubMed ID: 34569193)
1. Recombinant human thrombopoietin improved platelet engraftment after autologous hematopoietic stem cell transplantation in patients with newly diagnosed multiple myeloma.
Gu J; Liu J; Li X; Zou W; Huang B; Chen M; Li J
Cancer Med; 2021 Nov; 10(21):7641-7649. PubMed ID: 34569193
[TBL] [Abstract][Full Text] [Related]
2. Recombinant Human Thrombopoietin Promotes Platelet Engraftment in Severe Aplastic Anemia Patients Following Treatment With Haploid Hematopoietic Stem Cell Transplantation using Modified Post-Transplantation Cyclophosphamide.
Fu A; Peng Y; Cheng P; Wu J; Zhu X; Yang Y; Huang L; Wang N; Wang J; Xu J; Wan Y; Cao Y; Wei J; Xiao Y; Meng F; Cheng H; Zhang Y; Zhang D
Transplant Cell Ther; 2024 May; 30(5):500-509. PubMed ID: 38447750
[TBL] [Abstract][Full Text] [Related]
3. Recombinant human thrombopoietin promotes platelet engraftment after haploidentical hematopoietic stem cell transplantation: a prospective randomized controlled trial.
Han TT; Xu LP; Liu DH; Liu KY; Wang FR; Wang Y; Yan CH; Chen YH; Sun YQ; Ji Y; Wang JZ; Zhang XH; Huang XJ
Ann Hematol; 2015 Jan; 94(1):117-28. PubMed ID: 25069650
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of Recombinant Human Thrombopoietin for the Treatment of Secondary Failure of Platelet Recovery After Allogeneic HSCT.
Cao Y; Wang M; Shen B; Zhao F; Zhang R; Chen X; He Y; Zhai W; Ma Q; Wei J; Huang Y; Yang D; Pang A; Feng S; Jiang E; Han M
Clin Appl Thromb Hemost; 2022; 28():10760296211068037. PubMed ID: 35019756
[TBL] [Abstract][Full Text] [Related]
5. Oral eltrombopag versus subcutaneous recombinant human thrombopoietin for promoting platelet engraftment after allogeneic stem cell transplantation: A prospective, non-inferiority, randomized controlled trial.
Wen B; Zhang X; Chen S; Fan J; Yang S; Cai Y; Wang P; Zhang Q; Gu Q; Du X
Hematol Oncol; 2022 Oct; 40(4):777-786. PubMed ID: 35554955
[TBL] [Abstract][Full Text] [Related]
6. Recombinant human thrombopoietin in combination with granulocyte colony-stimulating factor enhances mobilization of peripheral blood progenitor cells, increases peripheral blood platelet concentration, and accelerates hematopoietic recovery following high-dose chemotherapy.
Somlo G; Sniecinski I; ter Veer A; Longmate J; Knutson G; Vuk-Pavlovic S; Bhatia R; Chow W; Leong L; Morgan R; Margolin K; Raschko J; Shibata S; Tetef M; Yen Y; Forman S; Jones D; Ashby M; Fyfe G; Hellmann S; Doroshow JH
Blood; 1999 May; 93(9):2798-806. PubMed ID: 10216073
[TBL] [Abstract][Full Text] [Related]
7. [Impact on platelet recovery of recombinant human thrombopoietin in severe aplastic anemia patients with allogeneic hematopoietic stem cell transplantation].
Song Y; Zhou F; Song NX; Liu XM; Yu Z; Xie LN; Song XC; Li X
Zhonghua Xue Ye Xue Za Zhi; 2018 Mar; 39(3):207-211. PubMed ID: 29562465
[No Abstract] [Full Text] [Related]
8. Recombinant human thrombopoietin augments mobilization of peripheral blood progenitor cells for autologous transplantation.
Linker C; Anderlini P; Herzig R; Christiansen N; Somlo G; Bensinger W; Fay J; Lynch JP; Goodnough LT; Ashby M; Benyunes MC; Jones DV; Yang TA; Miller LL; Weaver C
Biol Blood Marrow Transplant; 2003 Jun; 9(6):405-13. PubMed ID: 12813449
[TBL] [Abstract][Full Text] [Related]
9. A phase I trial of recombinant human thrombopoietin in patients with delayed platelet recovery after hematopoietic stem cell transplantation.
Nash RA; Kurzrock R; DiPersio J; Vose J; Linker C; Maharaj D; Nademanee AP; Negrin R; Nimer S; Shulman H; Ashby M; Jones D; Appelbaum FR; Champlin R
Biol Blood Marrow Transplant; 2000; 6(1):25-34. PubMed ID: 10707996
[TBL] [Abstract][Full Text] [Related]
10. Safety of recombinant human thrombopoietin in adults after related donor haploidentical haematopoietic stem cell transplantation: a pilot study.
Liu DH; Huang XJ; Liu KY; Xu LP; Chen YH; Wang Y; Han W; Chen H
Clin Drug Investig; 2011; 31(2):135-41. PubMed ID: 21062103
[TBL] [Abstract][Full Text] [Related]
11. Effect of c-mpl ligands after total body irradiation (TBI) with and without allogeneic hematopoietic stem cell transplantation: low-dose TBI does not prevent sensitization.
Nash RA; Takatu A; Feng Z; Slichter S; Abrams K; Espino G; Gass MJ; Georges GE; McSweeney PA; Shulman HM; Storb R
Biol Blood Marrow Transplant; 2002; 8(7):360-7. PubMed ID: 12171482
[TBL] [Abstract][Full Text] [Related]
12. Factors that predict delayed platelet recovery after autologous stem cell transplantation for lymphoma or myeloma.
Nagayama T; Ashizawa M; Ikeda T; Kawaguchi SI; Toda Y; Ito S; Ochi SI; Mashima K; Umino K; Minakata D; Nakano H; Yamasaki R; Morita K; Kawasaki Y; Yamamoto C; Fujiwara SI; Hatano K; Sato K; Oh I; Ohmine K; Muroi K; Kanda Y
Ann Hematol; 2020 Dec; 99(12):2893-2901. PubMed ID: 32572522
[TBL] [Abstract][Full Text] [Related]
13. CD34+ hematopoietic progenitor cell dose as a predictor of engraftment and survival in multiple myeloma patients undergoing autologous stem cell transplantation.
Aladağ Karakulak E; Demiroğlu H; Büyükaşik Y; Turgut M; Aksu S; Sayinalp N; Haznedaroğlu IC; Özcebe OI; Göker H
Turk J Med Sci; 2020 Dec; 50(8):1851-1856. PubMed ID: 32512672
[TBL] [Abstract][Full Text] [Related]
14. Recombinant human thrombopoietin promotes platelet engraftment after umbilical cord blood transplantation.
Tang B; Huang L; Liu H; Cheng S; Song K; Zhang X; Yao W; Ning L; Wan X; Sun G; Wu Y; Cheng J; Long Q; Sun Z; Zhu X
Blood Adv; 2020 Aug; 4(16):3829-3839. PubMed ID: 32790845
[TBL] [Abstract][Full Text] [Related]
15. A novel recombinant human thrombopoietin for treating prolonged isolated thrombocytopenia after allogeneic stem cell transplantation.
Sun YQ; Kong Y; Zhang XH; Wang Y; Shi MM; Song Y; Kong J; Fu HX; Yan CH; Xu LP; Liu KY; Huang XJ
Platelets; 2019; 30(8):994-1000. PubMed ID: 30569802
[TBL] [Abstract][Full Text] [Related]
16. Recombinant human thrombopoietin (rhTPO) after autologous bone marrow transplantation: a phase I pharmacokinetic and pharmacodynamic study.
Wolff SN; Herzig R; Lynch J; Ericson SG; Greer JP; Stein R; Goodman S; Benyunes MC; Ashby M; Jones DV; Fay J
Bone Marrow Transplant; 2001 Feb; 27(3):261-8. PubMed ID: 11277173
[TBL] [Abstract][Full Text] [Related]
17. Tbo-Filgrastim versus Filgrastim during Mobilization and Neutrophil Engraftment for Autologous Stem Cell Transplantation.
Elayan MM; Horowitz JG; Magraner JM; Shaughnessy PJ; Bachier C
Biol Blood Marrow Transplant; 2015 Nov; 21(11):1921-5. PubMed ID: 26033279
[TBL] [Abstract][Full Text] [Related]
18. Failure to achieve a threshold dose of CD34+CD110+ progenitor cells in the graft predicts delayed platelet engraftment after autologous stem cell transplantation for multiple myeloma.
Wallington-Beddoe CT; Gottlieb DJ; Garvin F; Antonenas V; Sartor MM
Biol Blood Marrow Transplant; 2009 Nov; 15(11):1386-93. PubMed ID: 19822297
[TBL] [Abstract][Full Text] [Related]
19. Recombinant Human Thrombopoietin Promotes Platelet Engraftment and Improves Prognosis of Patients with Myelodysplastic Syndromes and Aplastic Anemia after Allogeneic Hematopoietic Stem Cell Transplantation.
Wang H; Huang M; Zhao Y; Qi JQ; Chen C; Tang YQ; Qiu HY; Fu CC; Tang XW; Wu DP; Ruan CG; Han Y
Biol Blood Marrow Transplant; 2017 Oct; 23(10):1678-1684. PubMed ID: 28642072
[TBL] [Abstract][Full Text] [Related]
20. [Clinical tolerance test of recombinant human thrombopoietin].
Zhao Y; Jiang J; Jiao L
Zhonghua Yi Xue Za Zhi; 2001 Dec; 81(24):1508-11. PubMed ID: 16200777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]